Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

XBIvsPTHETF Comparison

ETF 1
XBI

State Street SPDR S&P Biotech ETF

This fund is part of
US Health Care
-0.03%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-0.03%

State Street SPDR S&P Biotech ETF (XBI) and Invesco DWA Healthcare Momentum ETF (PTH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XBI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.72% for PTH. XBI is up 7.52% year-to-date (YTD) with +$23M in YTD flows. PTH performs worse with 1.75% YTD performance, and -$6M in YTD flows. Run a side-by-side ETF comparison of XBI and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XBI vs PTH performance and flow charts

Performance

051015%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-400,000,000-200,000,0000200,000,000400,000,000600,000,000800,000,000Mar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/28/2026
1M3MYTD1Y3Y5Y
Perf.
XBI
PTH
+10.37%+8.86%
+4.13%+4.25%
+7.52%+1.75%
+61.71%+32.72%
+64.28%+30.38%
-5.68%-2.01%
Flows
XBI
PTH
+$514M-$498K
-$371M-$5M
+$23M-$6M
+$555M-$10M
-$1.24B-$80M
+$958M-$357M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XBI
PTH
+30.05%+27.25%
+25.87%+23.02%
+27.40%+24.62%
+32.69%+25.29%
Max drawdown
XBI
PTH
-7.98%-7.51%
-9.66%-11.91%
-32.94%-29.24%
-55.10%-50.10%
Max drawdown duration
XBI
PTH
42d40d
76d140d
331d271d
1826d1699d
Trading data

Create an account to view trading data

Join for free
XBI
PTH
Last sale
4/29/2026 at 2:49 PM
$129.00
$50.71
Previous close
04/28/2026
$131.16
$52.10
Consolidated volume
04/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XBI
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/29/2026 at 2:49 PM
Live
Closed
XBI
PTH
Last price
$129.00
$50.71
1D performance
-1.65%
-2.68%
AuM$8.42 B$121.40 M
E/R0.35%0.72%
Characteristics
XBI
PTH
Management strategyPassivePassive
ProviderState Street Investment ManagementInvesco
BenchmarkS&P Biotechnology Select Industry IndexDorsey Wright Healthcare Technical Leaders Index
N° of holdings12246
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 31, 2006October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

XBI
USA
95.16%
Other
4.84%
PTH
USA
94.53%
Other
5.47%

Sectors

XBI
Health Care
86.79%
Other
13.21%
PTH
Health Care
85.2%
Other
14.8%
Advertisement

Diversification

XBI

Total weight of top 15 holdings out of 15

19.71%
PTH

Total weight of top 15 holdings out of 15

52.67%

Top 15 holdings

Data as of March 31, 2026
XBI
APELLIS PHARMACEUTICALS
1.83%
ALKERMES
1.45%
MADRIGAL PHARMACEUTICALS INC
1.38%
TG THERAPEUTICS
1.35%
INSMED
1.34%
SCHOLAR ROCK HOLDING CORP
1.30%
US03770N1019
1.28%
PROTAGONIST THERAPEUTICS INC
1.25%
US86627T1088
1.24%
UTD THERAPEUT
1.24%
US74006W2070
1.24%
ARROWHEAD PHARMACEUTICALS INC
1.23%
COGENT BIOSCIENCES
1.22%
BRIDGEBIO PHARMA
1.19%
PTC THERAPEUTI/D
1.18%
PTH
TERNS PHARMACEUTICALS
6.73%
ROIVANT SCIENCES LTD
5.47%
US74006W2070
5.15%
ARROWHEAD PHARMACEUTICALS INC
3.66%
GUARDANT HEALTH INC
3.47%
REVOLUTION MEDICINES INC
3.32%
TENET HEALTHCARE
3.16%
UTD THERAPEUT
2.99%
NATERA
2.95%
HCA HEALTHCARE
2.89%
CELCUITY INC
2.88%
AXSOME THERA CMN STK
2.58%
MADRIGAL PHARMACEUTICALS INC
2.58%
PROTAGONIST THERAPEUTICS INC
2.43%
COGENT BIOSCIENCES
2.40%
Frequently asked questions about XBI and PTH

How have the XBI and PTH ETFs performed in 2026?

As of April 28, 2026, XBI is up 7.52% year-to-date (YTD), while PTH has returned 1.75%. That puts XBI better performer ahead so far this year.

Which ETF is attracting more investor money: XBI or PTH?

Year-to-date, the XBI ETF saw +$23M in flows, compared to -$6M for PTH.

Which ETF is more volatile: XBI or PTH?

Over the past year, XBI had a volatility of 25.87%, while PTH experienced 23.02%.

Which ETF is bigger: XBI or PTH?

As of April 28, 2026, XBI holds $8.42 B in assets under management (AUM), while PTH manages $121.40 M.

What sectors do the XBI and PTH ETFs invest in?

XBI leans toward sectors like Health Care. Meanwhile, PTH focuses on Health Care.

What are the top holdings of the XBI ETF and PTH ETF?

XBI top holdings include APELLIS PHARMACEUTICALS, ALKERMES and MADRIGAL PHARMACEUTICALS INC. PTH holds in its top three: TERNS PHARMACEUTICALS, ROIVANT SCIENCES LTD and US74006W2070.

Which ETF is more diversified: XBI or PTH?

XBI holds 151 securities with 19.71% of its assets in the top 15. PTH has 57 securities and a top 15 weight of 52.67%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast